CNY 22.22
(10.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 859.57 Million CNY | -1.22% |
2022 | 870.21 Million CNY | -3.21% |
2021 | 899.05 Million CNY | 8.68% |
2020 | 827.23 Million CNY | 9.19% |
2019 | 757.64 Million CNY | 10.13% |
2018 | 687.95 Million CNY | 106.44% |
2017 | 333.25 Million CNY | 13.16% |
2016 | 294.5 Million CNY | 63.36% |
2015 | 180.28 Million CNY | 55.68% |
2014 | 115.8 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 835.89 Million CNY | -0.92% |
2024 Q1 | 843.67 Million CNY | -1.85% |
2024 Q3 | 840.59 Million CNY | 0.56% |
2023 Q2 | 824.94 Million CNY | -0.14% |
2023 Q4 | 859.57 Million CNY | 2.63% |
2023 Q3 | 837.58 Million CNY | 1.53% |
2023 FY | 859.57 Million CNY | -1.22% |
2023 Q1 | 826.12 Million CNY | -5.07% |
2022 Q2 | 877.49 Million CNY | 0.86% |
2022 FY | 870.21 Million CNY | -3.21% |
2022 Q4 | 870.21 Million CNY | 1.46% |
2022 Q3 | 857.68 Million CNY | -2.26% |
2022 Q1 | 870.04 Million CNY | -3.23% |
2021 FY | 899.05 Million CNY | 8.68% |
2021 Q4 | 899.05 Million CNY | 2.17% |
2021 Q3 | 879.95 Million CNY | 6.84% |
2021 Q2 | 823.65 Million CNY | 1.0% |
2021 Q1 | 815.48 Million CNY | -1.42% |
2020 Q1 | 735.39 Million CNY | -2.94% |
2020 Q3 | 767.99 Million CNY | 3.45% |
2020 Q4 | 827.23 Million CNY | 7.71% |
2020 FY | 827.23 Million CNY | 9.19% |
2020 Q2 | 742.37 Million CNY | 0.95% |
2019 Q4 | 757.64 Million CNY | 7.0% |
2019 FY | 757.64 Million CNY | 10.13% |
2019 Q3 | 708.05 Million CNY | 4.14% |
2019 Q2 | 679.9 Million CNY | 0.1% |
2019 Q1 | 679.25 Million CNY | -1.26% |
2018 Q1 | - CNY | -100.0% |
2018 FY | 687.95 Million CNY | 106.44% |
2018 Q4 | 687.95 Million CNY | 83.03% |
2018 Q3 | 375.87 Million CNY | 3.26% |
2018 Q2 | 364.01 Million CNY | 0.0% |
2017 FY | 333.25 Million CNY | 13.16% |
2017 Q4 | 333.25 Million CNY | 0.0% |
2016 FY | 294.5 Million CNY | 63.36% |
2015 FY | 180.28 Million CNY | 55.68% |
2014 FY | 115.8 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 15.96 Billion CNY | 94.617% |
Shenzhen Salubris Pharmaceuticals Co., Ltd. | 9.39 Billion CNY | 90.852% |
Blue Sail Medical Co.,Ltd. | 15.63 Billion CNY | 94.502% |
Andon Health Co., Ltd. | 22.61 Billion CNY | 96.2% |
Allmed Medical Products Co., Ltd | 5.08 Billion CNY | 83.094% |
Improve Medical Instruments Co., Ltd. | 1.42 Billion CNY | 39.72% |
Tofflon Science and Technology Group Co., Ltd. | 12.89 Billion CNY | 93.336% |
Truking Technology Limited | 11.66 Billion CNY | 92.629% |
Jiangxi Sanxin Medtec Co.,Ltd. | 2.03 Billion CNY | 57.673% |
Shenyang Xingqi Pharmaceutical Co.,Ltd | 2.02 Billion CNY | 57.528% |
Autek China Inc. | 5.51 Billion CNY | 84.425% |
Intco Medical Technology Co., Ltd. | 27.07 Billion CNY | 96.826% |
Winner Medical Co., Ltd. | 17.11 Billion CNY | 94.977% |
Imeik Technology Development Co.,Ltd. | 6.85 Billion CNY | 87.456% |
Zhonghong Pulin Medical Products Co., Ltd. | 7.05 Billion CNY | 87.82% |
Caina Technology Co., Ltd. | 1.92 Billion CNY | 55.442% |